Articles Posted in Januvia/Janumet

Information on pancreatic cancer lawsuits involving Januvia and Jamumet.

Published on:

pills2According to a recent news release, regulators in Europe have concluded that there is little evidence that widely used drugs to treat Type 2 diabetes could cause pancreatic inflammation or pancreatic cancer.

Besides the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon, and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca.  These drugs, called incretin mimetics by the FDA, increase the body’s levels of a hormone that helps to control blood sugar levels.

They have, however, been linked to pancreatic inflammation known as pancreatitis.  While the European agency said that the clinical trials had shown no increased risk of pancreatic cancer, the FDA said the trials were too small to draw firm conclusions.

Published on:

Here are some of the stories we’re following this week:

  • Janumet: Shearlings Got Plowed reports that the FDA is revising the label for Janumet to warn about pancreatitis. A link to the FDA’s prescribing information is here
  • Seroquel: Tom Lamb reports on the difficulties that plaintiffs are facing in these cases, of late. It seems that the odds are against us and the situation is grim—a good time for a reversal
Published on:

People with type 2 diabetes taking the drugs Januvia or Byetta might have an increased risk of developing pancreatitis and pancreatic cancer.  Our law firm is handling lawsuits on behalf of patients who were taking Januvia, Janumet, or Byetta.

We can all agree that these drugs are good at fighting diabetes, which is an awful disease.  But there are a lot of drugs that fight diabetes.  These drugs might be a little cheaper than some.  But the problem with Januvia is that if it impacts the pancreas in a way that can cause it serious injury like pancreatitis, and even more seriously, pancreatic cancer.

Pancreatic cancer occurs when cancerous cells form in the tissues of the pancreas. The majority of pancreatic cancers start in what is called exocrine cells.